EP3597189
KRISTÖLLUÐ EFNASAMBÖND
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
17.6.2016EP published:
1.6.2022EP application number:
19196556.5
EP translation filed:
10.6.2022Grant published:
15.7.2022EPO information:
European Patent Register
Max expiry date:
16.6.2036Expiry date:
16.6.2026Next due date:
30.6.2026
Title in English:
CRYSTALLINE COMPOUNDSLanguage of the patent:
English
Timeline
Today
17.6.2016EP application
1.6.2022EP Publication
10.6.2022Translation submitted
15.7.2022Registration published
16.6.2026Expires
Owner
Name:
Otsuka America Pharmaceutical, Inc.Address:
2440 Research Boulevard, Rockville, MD 20850, US
Inventor
Name:
MCKINNEY, Anthony AlexanderAddress:
Newton Center, MA 02459, US
Name:
BYMASTER, FranklinAddress:
Brownsburg, IN 46112, US
Name:
PISKORSKI, WalterAddress:
Nashua, NH 03062, US
Name:
FLEITZ, Fred J.Address:
Germantown, WI 53022, US
Name:
YANG, YonglaiAddress:
Hockessin, DE 19707, US
Name:
ENGERS, David A.Address:
West Lafayette, IN 47906, US
Name:
SMOLENSKAYA, ValeriyaAddress:
West Lafayette, IN 47906, US
Name:
KUSUKUNTLA, VenkatAddress:
Germantown, WI 53022, US
Agent
Name:
G.H. Sigurgeirsson ehf.Address:
Borgartúni 26, 105, Reykjavík,
Priority
Number:
201562181174 PDate:
17.6.2015Country:
US
Classification
Categories:
A61K 31/403, C07D 209/52, A61K 45/06
Annual fees
Number
Paid
Expires
Payer
Number: 7
Paid: 28.7.2022
Expires: 16.6.2023
Payer: G.H. Sigurgeirsson ehf.
Number: 8
Paid: 24.5.2023
Expires: 16.6.2024
Payer: Árnason Faktor ehf.
Number: 9
Paid: 7.5.2024
Expires: 16.6.2025
Payer: Árnason Faktor ehf.
Number: 10
Paid: 4.6.2025
Expires: 16.6.2026
Payer: Árnason Faktor ehf.